Close X
Friday, November 22, 2024
ADVT 
Health

News of potential COVID vaccine 'encouraging': PM

Darpan News Desk The Canadian Press, 09 Nov, 2020 06:07 PM
  • News of potential COVID vaccine 'encouraging': PM

Prime Minister Justin Trudeau says he hopes to see COVID-19 vaccines roll out in Canada early next year, but warns that won't bring an immediate resolution to the pandemic currently seeing a resurgence in several provinces.

The prime minister says news from Pfizer today that one of its vaccine candidates appears very effective in clinical trials is "very encouraging" but won't help anyone who catches the virus in the meantime.

Speaking in Ottawa, Trudeau said other vaccine candidates have also appeared to progress well.

His comments come after a weekend that saw the two provinces hardest hit by the pandemic report record-breaking daily case counts.

Quebec reported 1,397 new cases on Sunday and Ontario reported 1,328, nearly 200 more than the record it had set the previous day.

The number of new infections stayed above 1,000 in Ontario on Monday, with 1,242 reported.

Canada has bought the rights to 20 million doses of Pfizer's vaccine, if it proves effective and Health Canada approves it for use here, and Trudeau said the government would purchase more if the initial round goes well.

The company said in a news release that early results from a large-scale trial show its vaccine is 90 per cent effective at combating the virus.

Tedros Adhanom Ghebreyesus with the World Health Organization also reacted to the good news via Twitter.

"We hope to see vaccines landing in the early next year but between now and then it's really really important that we double down on our efforts," Trudeau said.

"We need to make sure we are controlling the spread of COVID-19 in the coming months so that when vaccines get here we will be able to act quickly to protect all Canadians."

MORE Health ARTICLES

Serious coronavirus-linked condition hit 285 US children

Serious coronavirus-linked condition hit 285 US children
At least 285 U.S. children have developed a serious inflammatory condition linked to the coronavirus and while most recovered, the potential for long-term or permanent damage is unknown, two new studies suggest.

Serious coronavirus-linked condition hit 285 US children

Tattoo artist sees bump in desire to erase hateful skin art

Tattoo artist sees bump in desire to erase hateful skin art
A Vermont tattoo artist who has long offered free removal or covering of hateful skin art like swastikas, SS lightning bolts or the words “white power” says he’s seen an uptick in business recently following George Floyd's death.

Tattoo artist sees bump in desire to erase hateful skin art

Travellers to NY, New Jersey, Connecticut are told to isolate

Travellers to NY, New Jersey, Connecticut are told to isolate
New York, Connecticut and New Jersey will require visitors from states with high infection rates to quarantine for 14 days, New York Gov. Andrew Cuomo said Wednesday.

Travellers to NY, New Jersey, Connecticut are told to isolate

Open wide: US dentists quickly rebuild after virus shutdown

Open wide: US dentists quickly rebuild after virus shutdown
U.S. dental offices are quickly bouncing back, but it won't be business as usual. Expect social distancing, layers of protective gear and a new approach to some procedures to guard against coronavirus.

Open wide: US dentists quickly rebuild after virus shutdown

Virus cases surging among the young, endangering the elderly

Virus cases surging among the young, endangering the elderly
Coronavirus cases are climbing rapidly among young adults in a number of states where bars, stores and restaurants have reopened — a disturbing generational shift that not only puts them in greater peril than many realize but poses an even bigger danger to older people who cross their paths.

Virus cases surging among the young, endangering the elderly

Vancouver biotech company discovering antibodies for COVID-19 treatment

Vancouver biotech company discovering antibodies for COVID-19 treatment
There may be another valuable shield in the fight against COVID-19, and the head of a Vancouver biotech firm says it could buy time as researchers race to develop a vaccine. Carl Hansen, CEO of AbCellera Biologics Inc., said a drug built with antibodies could be used to protect vulnerable populations until a vaccine is more widely available.    

Vancouver biotech company discovering antibodies for COVID-19 treatment